Point of Care
The developed automatic station standardizes and reduces the duration of direct human involvement in the process of CAR-T cells production, as well as increases reproducibility. As a result, the CAR-T therapy can be provided to a larger number of people.
From sketch
Correction of defects caused by changes in the structure of DNA or DNA damages of viral etiology, changing of cell functions is a new and rapidly developing field of gene engineering. The Point оf Care station was designed for adoptive cellular immunotherapy (ACI) carried out by transfer of Т-cells. ACI includes ex vivo expansion of tumor cell-specific T-cells and further reinfusion into a patient’s organism. According to the experts’ point of view, this therapy is one of the most promising methods discovered over the past decade allowing to overcome oncological and autoimmune diseases.